Human activated T lymphocytes modulate IDO expression in tumors through Th1/Th2 balance. 2009

Jessica Godin-Ethier, and Sandy Pelletier, and Laïla-Aïcha Hanafi, and Philippe O Gannon, and Marie-Andrée Forget, and Jean-Pierre Routy, and Mohamed-Rachid Boulassel, and Urszula Krzemien, and Simon Tanguay, and Jean-Baptiste Lattouf, and Nathalie Arbour, and Réjean Lapointe
Research Centre, Centre Hospitalier de l'Université de Montréal-Hôpital Notre-Dame, Université de Montréal and Institut du Cancer de Montréal, Montreal, Quebec, Canada.

Previous cancer vaccination approaches have shown some efficiency in generating measurable immune responses, but they have rarely led to tumor regression. It is therefore possible that tumors emerge with the capacity to down-regulate immune counterparts, through the local production of immunosuppressive molecules, such as IDO. Although it is known that IDO exerts suppressive effects on T cell functions, the mechanisms of IDO regulation in tumor cells remain to be characterized. Here, we demonstrate that activated T cells can induce functional IDO expression in breast and kidney tumor cell lines, and that this is partly attributable to IFN-gamma. Moreover, we found that IL-13, a Th2 cytokine, has a negative modulatory effect on IDO expression. Furthermore, we report IDO expression in the majority of breast and kidney carcinoma samples, with infiltration of activated Th1-polarized T cells in human tumors. These findings demonstrate complex control of immune activity within tumors. Future immune therapeutic interventions should thus include strategies to counteract these negative mechanisms.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015971 Gene Expression Regulation, Enzymologic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in enzyme synthesis. Enzymologic Gene Expression Regulation,Regulation of Gene Expression, Enzymologic,Regulation, Gene Expression, Enzymologic
D016130 Immunophenotyping Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry. Lymphocyte Immunophenotyping,Lymphocyte Subtyping,Immunologic Subtyping,Immunologic Subtypings,Lymphocyte Phenotyping,Subtyping, Immunologic,Subtypings, Immunologic,Immunophenotyping, Lymphocyte,Immunophenotypings,Immunophenotypings, Lymphocyte,Lymphocyte Immunophenotypings,Lymphocyte Phenotypings,Lymphocyte Subtypings,Phenotyping, Lymphocyte,Phenotypings, Lymphocyte,Subtyping, Lymphocyte,Subtypings, Lymphocyte
D016246 Lymphocytes, Tumor-Infiltrating Lymphocytes that show specificity for autologous tumor cells. Ex vivo isolation and culturing of TIL with interleukin-2, followed by reinfusion into the patient, is one form of adoptive immunotherapy of cancer. Tumor Infiltrating Lymphocyte,Tumor-Derived Activated Cell,Tumor-Derived Activated Cells,Tumor-Infiltrating Lymphocyte,Tumor-Infiltrating Lymphocytes,Activated Cell, Tumor-Derived,Activated Cells, Tumor-Derived,Infiltrating Lymphocyte, Tumor,Infiltrating Lymphocytes, Tumor,Lymphocyte, Tumor Infiltrating,Lymphocyte, Tumor-Infiltrating,Lymphocytes, Tumor Infiltrating,Tumor Derived Activated Cell,Tumor Derived Activated Cells,Tumor Infiltrating Lymphocytes

Related Publications

Jessica Godin-Ethier, and Sandy Pelletier, and Laïla-Aïcha Hanafi, and Philippe O Gannon, and Marie-Andrée Forget, and Jean-Pierre Routy, and Mohamed-Rachid Boulassel, and Urszula Krzemien, and Simon Tanguay, and Jean-Baptiste Lattouf, and Nathalie Arbour, and Réjean Lapointe
December 2002, Journal of neuroimmunology,
Jessica Godin-Ethier, and Sandy Pelletier, and Laïla-Aïcha Hanafi, and Philippe O Gannon, and Marie-Andrée Forget, and Jean-Pierre Routy, and Mohamed-Rachid Boulassel, and Urszula Krzemien, and Simon Tanguay, and Jean-Baptiste Lattouf, and Nathalie Arbour, and Réjean Lapointe
August 1998, Transplantation proceedings,
Jessica Godin-Ethier, and Sandy Pelletier, and Laïla-Aïcha Hanafi, and Philippe O Gannon, and Marie-Andrée Forget, and Jean-Pierre Routy, and Mohamed-Rachid Boulassel, and Urszula Krzemien, and Simon Tanguay, and Jean-Baptiste Lattouf, and Nathalie Arbour, and Réjean Lapointe
May 2003, Journal of immunology (Baltimore, Md. : 1950),
Jessica Godin-Ethier, and Sandy Pelletier, and Laïla-Aïcha Hanafi, and Philippe O Gannon, and Marie-Andrée Forget, and Jean-Pierre Routy, and Mohamed-Rachid Boulassel, and Urszula Krzemien, and Simon Tanguay, and Jean-Baptiste Lattouf, and Nathalie Arbour, and Réjean Lapointe
September 2015, Allergology international : official journal of the Japanese Society of Allergology,
Jessica Godin-Ethier, and Sandy Pelletier, and Laïla-Aïcha Hanafi, and Philippe O Gannon, and Marie-Andrée Forget, and Jean-Pierre Routy, and Mohamed-Rachid Boulassel, and Urszula Krzemien, and Simon Tanguay, and Jean-Baptiste Lattouf, and Nathalie Arbour, and Réjean Lapointe
April 2011, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
Jessica Godin-Ethier, and Sandy Pelletier, and Laïla-Aïcha Hanafi, and Philippe O Gannon, and Marie-Andrée Forget, and Jean-Pierre Routy, and Mohamed-Rachid Boulassel, and Urszula Krzemien, and Simon Tanguay, and Jean-Baptiste Lattouf, and Nathalie Arbour, and Réjean Lapointe
August 2003, Journal of reproductive immunology,
Jessica Godin-Ethier, and Sandy Pelletier, and Laïla-Aïcha Hanafi, and Philippe O Gannon, and Marie-Andrée Forget, and Jean-Pierre Routy, and Mohamed-Rachid Boulassel, and Urszula Krzemien, and Simon Tanguay, and Jean-Baptiste Lattouf, and Nathalie Arbour, and Réjean Lapointe
January 1999, Springer seminars in immunopathology,
Jessica Godin-Ethier, and Sandy Pelletier, and Laïla-Aïcha Hanafi, and Philippe O Gannon, and Marie-Andrée Forget, and Jean-Pierre Routy, and Mohamed-Rachid Boulassel, and Urszula Krzemien, and Simon Tanguay, and Jean-Baptiste Lattouf, and Nathalie Arbour, and Réjean Lapointe
January 1999, Springer seminars in immunopathology,
Jessica Godin-Ethier, and Sandy Pelletier, and Laïla-Aïcha Hanafi, and Philippe O Gannon, and Marie-Andrée Forget, and Jean-Pierre Routy, and Mohamed-Rachid Boulassel, and Urszula Krzemien, and Simon Tanguay, and Jean-Baptiste Lattouf, and Nathalie Arbour, and Réjean Lapointe
January 1997, International archives of allergy and immunology,
Jessica Godin-Ethier, and Sandy Pelletier, and Laïla-Aïcha Hanafi, and Philippe O Gannon, and Marie-Andrée Forget, and Jean-Pierre Routy, and Mohamed-Rachid Boulassel, and Urszula Krzemien, and Simon Tanguay, and Jean-Baptiste Lattouf, and Nathalie Arbour, and Réjean Lapointe
June 2022, Pharmacological reports : PR,
Copied contents to your clipboard!